Oct 7 (Reuters) - Repare Therapeutics Inc RPTX.O :
* REPARE THERAPEUTICS -ISSUES STATEMENT ON INADVERTENT
ISSUANCE OF
ABSTRACT BY AACR-NCI-EORTC VIRTUAL INTERNATIONAL CONFERENCE ON
MOLECULAR TARGETS AND CANCER THERAPEUTICS
* REPARE THERAPEUTICS - ANE CONFERENCE ISSUED EARLY ABSTRACT
HIGHLIGHTING UPCOMING ORAL PRESENTATION OF INITIAL MONOTHERAPY
CLINICAL DATA FROM ONGOING PHASE 1/2 CLINICAL TRIAL OF RP-3500
* REPARE THERAPEUTICS INC - ABSTRACT HIGHLIGHTS RESULTS
TAKEN FROM
A VERY EARLY CUTOFF DATE FOR ONGOING STUDY, CURRENTLY IN ITS
PHASE 1 PORTION
* REPARE THERAPEUTICS - ORAL PRESENTATION, EXPECTED TO TAKE
PLACE
ON OCT 8, TO INCLUDE SIGNIFICANTLY MORE PATIENT DATA, LATER CUT
OFF DATE & CONSEQUENT LONGER FOLLOW UP
Source text for Eikon: ID:nBw91Bhsma
Further company coverage: RPTX.O
((Reuters.Briefs@thomsonreuters.com;))